Moderna cuts high end of 2025 revenue outlook on vaccine shipment delay in U.K.

Bearish -63.0
Moderna also lost less than Wall Street analysts were expecting for the second quarter and posted revenue that topped estimates. 
Read Source Login to use Pulse AI

Pulse AI Analysis

Pulse analysis not available yet. Click "Get Pulse" above.

This analysis was generated using Pulse AI, Glideslope's proprietary AI engine designed to interpret market sentiment and economic signals. Results are for informational purposes only and do not constitute financial advice.